Founded in 2019, Saveo operates in Health Tech industry. Initially focused on improving pharmaceutical distribution through a marketplace model, Saveo evolved by integrating technology to enhance inve...
Funding stage:
Seed
Last funding:
26/09/2022
Total funding:
$8.78 Mn+
Revenue:
Investors
Employee count:
164
Last 90d
164
Last 90d
Web traffic:
926
926
Last 30d
Last 30d
Glassdoor Rating:
Saveo: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders57
Latest Filing Date21 Nov 2025- Funding Events28
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Saveo
As of 22 November 2025, Saveo's equity is held by 56 shareholders, with the top three being Scov3, RTP Global Partners III LP, and Shivansh Shrivastava.
Scov3 holds the largest stake in Saveo at 15.2% as of 22 November 2025.
As of 22 November 2025, founders collectively hold 19.3% equity in Saveo.
As of 22 November 2025, investors collectively hold 54.6% equity in Saveo.
Saveo's ESOP pool stands at 3.5% of total equity as of 22 November 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links